When a celebrity becomes the face of a medical platform, sciences credibility is leveraged for marketing without the scrutiny that medicine demands
Metformin suppresses hepatic gluconeogenesis and lowers fasting blood glucose levels through reactive nitrogen species in mice.Diabetologia,531472-1481 7.Collins L, Costello RA
Here's what the trials have shown: Phase 1b Trial Results (Lancet 2022) The initial Phase 1b study evaluated retatrutide safety, tolerability, and pharmacokinetics in 72 adults with type 2 diabetes over 12 weeks
To validate the clinical relevance of these orally bioavailable small-molecule GLP1RAs, we confirmed that oral danuglipron significantly reduced blood glucose levels (Fig
Additionally, they only included patients with diabetes, although GLP-1 RAs are used to treat other conditions, such as obesity, and to reduce cardiovascular disease risk